<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Helwick, Caroline</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Meneghini, Luigi F.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">PREDICTIVE 303: Patient Self-Adjusted Dosing a Safe and Effective Alternative</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">In the Predictable Results and Experience in Diabetes through Intensification and Control to Target: an International Variability Evaluation [PREDICTIVE 303] trial, patient-directed insulin dose adjustments of once-daily insulin detemir appeared to be a safe and effective alternative to physician-directed dose adjustments in a primary care setting.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>